Human Fallopian Tube – Derived Mesenchymal Stem Cells Inhibit Experimental Autoimmune Encephalomyelitis by Suppressing Th1/Th17 Activation and Migration to Central Nervous System

[1] Dominici M(2006)Minimal criteria for defining multipotent mesenchymal stromal cells The International Society for Cellular Therapy position statement Cytotherapy 28 261-273

[2] Le Blanc K(2000)Stem cells: Units of development, units of regeneration, and units in evolution Cell 24 386-398

[3] Mueller I(2011)Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases The Lancet Neurology 26 860-873

[4] Slaper-Cortenbach I(2018)Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-γ eBioMedicine 21 1758-1768

[5] Marini FC(2006)Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells Stem Cells 10 131-4126

[6] Krause DS(2018)IFN-γ and TNF-α pre-licensing protects mesenchymal stromal cells from the pro-inflammatory effects of palmitate Molecular Therapy 4 22-61

[7] Horwitz EM(2014)Interleukin-17 enhances immunosuppression by mesenchymal stem cells Cell Death & Differentiation 105 4120-312

[8] Weissman IL(2017)A regulatory miRNA–mRNA network is associated with tissue repair induced by mesenchymal stromal cells in acute kidney injury Frontiers in Immunology 22 55-34

[9] Uccelli A(2019)Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies Stem Cell Research & Therapy 185 302-7177

[10] Laroni A(2019)Mesenchymal stem cell perspective: Cell biology to clinical progress NPJ Regenerative Medicine 6 34-558

[1] Dominici M(2006)Minimal criteria for defining multipotent mesenchymal stromal cells The International Society for Cellular Therapy position statement Cytotherapy 28 261-273

[2] Le Blanc K(2000)Stem cells: Units of development, units of regeneration, and units in evolution Cell 24 386-398

[3] Mueller I(2011)Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases The Lancet Neurology 26 860-873

[4] Slaper-Cortenbach I(2018)Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-γ eBioMedicine 21 1758-1768

[5] Marini FC(2006)Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells Stem Cells 10 131-4126

[6] Krause DS(2018)IFN-γ and TNF-α pre-licensing protects mesenchymal stromal cells from the pro-inflammatory effects of palmitate Molecular Therapy 4 22-61

[7] Horwitz EM(2014)Interleukin-17 enhances immunosuppression by mesenchymal stem cells Cell Death & Differentiation 105 4120-312

[8] Weissman IL(2017)A regulatory miRNA–mRNA network is associated with tissue repair induced by mesenchymal stromal cells in acute kidney injury Frontiers in Immunology 22 55-34

[9] Uccelli A(2019)Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies Stem Cell Research & Therapy 185 302-7177

[10] Laroni A(2019)Mesenchymal stem cell perspective: Cell biology to clinical progress NPJ Regenerative Medicine 6 34-558